Olivier Cerles Selected Research

Olivier Cerles Research Topics

Disease

6	Neoplasms (Cancer) 11/2019 - 12/2014
6	Fibrosis (Cirrhosis) 01/2018 - 10/2015
4	Peripheral Nervous System Diseases (PNS Diseases) 11/2019 - 12/2014
3	Colonic Neoplasms (Colon Cancer) 11/2019 - 01/2017
3	Demyelinating Diseases (Demyelinating Disease) 11/2019 - 01/2017
3	Systemic Scleroderma (Systemic Sclerosis) 11/2016 - 10/2015
3	Inflammation (Inflammations) 10/2015 - 01/2015
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2017 - 10/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2016 - 10/2015
2	Endometriosis 09/2015 - 01/2015
1	Osteitis 01/2022
1	Multiple Sclerosis 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Carcinoma (Carcinomatosis) 02/2018
1	Neuralgia (Stump Neuralgia) 01/2017
1	Neuroinflammatory Diseases 01/2017
1	Hyperalgesia 01/2017
1	Hypesthesia (Numbness) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Alopecia (Baldness) 11/2016
1	Diarrhea 11/2016
1	Vasculitis (Vasculitides) 11/2016
1	Bronchiolitis Obliterans Syndrome 10/2015

Drug/Important Bio-Agent (IBA)

3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2019 - 01/2017
3	Dimethyl FumarateIBA 02/2018 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2018 - 12/2014
3	Niclosamide FDA Link 01/2017 - 10/2016
2	PlatinumIBA 01/2019 - 01/2017
2	AntioxidantsIBA 02/2018 - 01/2017
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2017 - 10/2016
2	AnthelminticsIBA 11/2016 - 10/2016
2	AutoantibodiesIBA 11/2016 - 10/2016
2	CateninsIBA 11/2016 - 10/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	Amoxicillin (Wymox)FDA LinkGeneric 01/2022
1	FluoroquinolonesIBA 01/2022
1	Superoxide DismutaseIBA 11/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Benztropine (Benzatropine)FDA LinkGeneric 01/2019
1	Dopamine (Intropin)FDA LinkGeneric 01/2019
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2019
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	CytokinesIBA 01/2019
1	Platinum Compounds (Compounds, Platinum)IBA 01/2019
1	Muscarinic M3 ReceptorIBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 02/2018
1	Transcription Factors (Transcription Factor)IBA 02/2018
1	AntibodiesIBA 01/2017
1	Leflunomide (Arava)FDA LinkGeneric 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 11/2016
1	pantetheinase (pantetheine hydrolase)IBA 10/2016
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2016
1	Minor Histocompatibility AntigensIBA 10/2015
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2015
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 09/2015
1	raf KinasesIBA 09/2015
1	Sorafenib (BAY 43-9006)FDA Link 09/2015
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2015
1	Mitogen-Activated Protein KinasesIBA 01/2015
1	Contraceptive Agents (Contraceptives)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 11/2019 - 12/2014
2	Therapeutics 01/2022 - 01/2015
1	Cell Transplantation 11/2016
1	Hematopoietic Stem Cell Transplantation 10/2015